Boston Historical Cash Flow
| 0HOY Stock | 90.94 1.30 1.45% |
Analysis of Boston Scientific cash flow over time is an excellent tool to project Boston Scientific Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 1.1 B or Begin Period Cash Flow of 898.8 M as it is a great indicator of Boston Scientific ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Boston Scientific Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Boston Scientific Corp is a good buy for the upcoming year.
Boston |
About Boston Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Boston balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Boston's non-liquid assets can be easily converted into cash.
Boston Scientific Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Depreciation
Depreciation indicates how much of Boston Scientific Corp value has been used up. For tax purposes Boston Scientific can deduct the cost of the tangible assets it purchases as business expenses. However, Boston Scientific Corp must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most accounts from Boston Scientific's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Boston Scientific's Other Non Cash Items is comparatively stable compared to the past year. Net Income is likely to gain to about 1.7 B in 2024, despite the fact that Change To Inventory is likely to grow to (627 M).
Boston Scientific cash flow statement Correlations
Click cells to compare fundamentals
Boston Scientific Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Boston Scientific cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 85M | 101M | 123M | (535M) | (615.3M) | (584.5M) | |
| Change To Inventory | (290M) | (65M) | (346M) | (321M) | (660M) | (627M) | |
| Change In Cash | (238M) | 1.4B | 173M | (1.0B) | (71M) | (67.5M) | |
| Stock Based Compensation | 157M | 170M | 194M | 220M | 233M | 163.3M | |
| Free Cash Flow | 1.4B | 1.1B | 1.3B | 938M | 1.8B | 1.1B | |
| Change In Working Capital | (282M) | 270M | (625M) | (541M) | (888M) | (843.6M) | |
| Begin Period Cash Flow | 801M | 607M | 2.0B | 2.2B | 1.1B | 898.8M | |
| Other Cashflows From Financing Activities | 56M | 2.1B | (40M) | 2.7B | 37M | 35.2M | |
| Depreciation | 1.0B | 1.1B | 1.1B | 1.1B | 1.2B | 1.0B | |
| Other Non Cash Items | (1.3B) | 27M | 167M | 13M | 370M | 652.6M | |
| Total Cash From Operating Activities | 1.8B | 1.5B | 1.9B | 1.5B | 2.5B | 1.5B | |
| Change To Account Receivables | (130M) | 335M | (279M) | (220M) | (238M) | (226.1M) | |
| Net Income | 4.7B | (82M) | 1.0B | 698M | 1.6B | 1.7B | |
| Total Cash From Financing Activities | 3.0B | 293M | (95M) | (548M) | 5M | 4.8M | |
| End Period Cash Flow | 563M | 2.0B | 2.2B | 1.1B | 1.1B | 967.0M | |
| Total Cashflows From Investing Activities | (5.0B) | (411M) | (1.6B) | (2.0B) | (1.8B) | (1.9B) | |
| Investments | (149M) | (146M) | 279M | (24M) | (27.6M) | (29.0M) | |
| Net Borrowings | 1.4B | 2.8B | (999M) | (165M) | (148.5M) | (141.1M) | |
| Change To Operating Activities | 45M | (265M) | (134M) | (209M) | (240.4M) | (252.4M) | |
| Change To Netincome | (3.6B) | 490M | 87M | 697M | 801.6M | 841.6M | |
| Change To Liabilities | 79M | (28M) | 408M | (255M) | (293.3M) | (278.6M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.